Septodont, a manufacturer of dental pharmaceuticals and medical devices, agreed to acquire dental care brands from Sanofi, a global biopharmaceutical company. Financial terms were not disclosed. Divested portfolio includes four dental care brands Ultracain, Rodogyl, Birodogyl and Dontisolon, as well as related medical devices, mostly marketed in Europe. This portfolio of high-quality medicines benefits patients both during and after dental operations, while covering most dental indications.